MedPath

The effect of Melatonin on stress induced hyperglycemia

Not Applicable
Conditions
Stress induced hyperglycemia.
Hyperglycemia, unspecified
R73.9
Registration Number
IRCT20100107003014N23
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
104
Inclusion Criteria

Age above 18 years old
Stress induced hyperglycemia (Blood sugar above 140) in the first 24 hours of admission in intensive care unit

Exclusion Criteria

Diabetes
HbA1C>7.5
Receiving glucocorticoids
Pregnant women
Allergy to Melatonin or its analogs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood sugar. Timepoint: Before intervention and the 4th day of intervention. Method of measurement: Blood test.;Homeostasis model assessment of insulin resistance. Timepoint: Before intervention and the 4th day of intervention. Method of measurement: Blood autoanalyser device? enzyme immunoassay and formula.;Homeostasis model assessment of adiponectin. Timepoint: Before intervention and the 4th day of intervention. Method of measurement: Blood autoanalyser device? enzyme immunoassay and formula.
Secondary Outcome Measures
NameTimeMethod
Delirium. Timepoint: Before intervention and 7th day of intervention. Method of measurement: Form (Reliability and Validity of the Richmond Agitation-Sedation Scale )(RASS).;Ventilator dependency. Timepoint: Before intervention and 7th day of intervention. Method of measurement: Form (have or do not have).;Quick sofa criteria. Timepoint: Before intervention and 7th day of intervention. Method of measurement: Form ( based on respiratory rate? blood pressure, change in mental status).;Admission days in intensive care unit. Timepoint: Up to last day of intensive care unit admission. Method of measurement: Data collecting form.
© Copyright 2025. All Rights Reserved by MedPath